Kineta completed a reverse merger with Yumanity Therapeutics with Kineta, Inc. as the surviving company effective December 19, 2022.
View Top Employees from Yumanity Therapeutics| Website | http://www.kinetabio.com |
| Revenue | $20 million |
| Funding | $46 million |
| Employees | 7 (7 on RocketReach) |
| Founded | 2014 |
| Address | 40 Guest St Ste 4410, Boston, Massachusetts 02135, US |
| Phone | (617) 409-5300 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Therapeutics |
| Web Rank | 13 Million |
| Keywords | C4 Therapeutics, Yumanity Therapeutics, Tony Coles Onyx, Yumanity, Reports On Yumanity Therapeutics |
| Competitors | Alkahest, Inc., Amylyx Pharmaceuticals, Cognition Therapeutics, Inc., Foldrx Pharmaceuticals, Neuraltus Pharmaceuticals |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Yumanity Therapeutics employee's phone or email?
Yumanity Therapeutics Questions
The Yumanity Therapeutics annual revenue was $20 million in 2024.
Tony Coles is the Chairman of Yumanity Therapeutics.
7 people are employed at Yumanity Therapeutics.
Yumanity Therapeutics is based in Boston, Massachusetts.
The NAICS codes for Yumanity Therapeutics are [54171, 54, 5417, 541714, 541].
The SIC codes for Yumanity Therapeutics are [87, 873].
Top Yumanity Therapeutics Employees
-
35
-
45+
-
11
-
15
Related Companies
